Caricamento...
Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes
Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different pro...
Salvato in:
| Pubblicato in: | J Blood Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278786/ https://ncbi.nlm.nih.gov/pubmed/25565910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S50482 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|